P. Bretton

DNA in situ sensitivity to denaturation in bladder cancer and its correlation with tumor stage.

M. Melamed, M. Kimmel, Z. Darżynkiewicz, 1990, Cancer research.

Prostate-Specific Antigen and Digital Rectal Examination in Screening for Prostate Cancer: A Community-Based Study

P. Bretton, PAUL R. BRETTON, 1994, Southern medical journal.

Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy.

H. Herr, P. Bretton, H. I. Winter, 1991, Urology.

Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer.

M. Melamed, M. Kimmel, R. Badalament, 1990, Journal of occupational medicine. : official publication of the Industrial Medical Association.

Initial evaluation of a new epithelial antigen (T16) for bivariate flow cytometry of bladder irrigation specimens.

M. Melamed, C. Cordon-Cardo, W. Fair, 1989, Cytometry.

Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra.

M. Melamed, M. Kimmel, R. Badalament, 1989, The Journal of urology.

The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.

V. Laudone, M. Kimmel, W. Fair, 1990, The Journal of urology.

The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma

W P Evans, P R Bretton, J D Borden, 1994, Cancer.

Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.

M. Melamed, M. Kimmel, W. Fair, 1989, The Journal of urology.

Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma

M. Melamed, R. Cote, W. Fair, 1994, The Prostate.